
    
      This study is an extension protocol for study A3051123. No treatment is provided during this
      study. This study is to monitor for cardiovascular events 28 weeks after completion of
      A3051123. This study is an extension protocol for study A3051123. No treatment is provided
      during this study. This study is to monitor for cardiovascular events 28 weeks after
      completion of A3051123.
    
  